Jamshid Motalebzadeh

Jamshid Motalebzadeh

Higher Degree by Research Candidate

Adelaide Medical School

Faculty of Health and Medical Sciences

With a broad range of research experience in bioinformatics, genetics, epigenetics, metabolomics, and molecular biology, I am eager to find new ways to alleviate cancer symptoms based on molecular-targeted therapies to elevate the quality of life for cancer patients.

  • Journals
    Year Citation
    2022 Motalebzadeh, J., & Eskandari, E. (2022). Comprehensive analysis of DRAIC and TP53TG1 in breast cancer luminal subtypes through the construction of lncRNAs regulatory model. Breast Cancer, 29(6), 1050-1066.
    DOI Scopus1
    2021 Shabani, S., Khayer, N., Motalebzadeh, J., Zadeh, T. M., & Mahjoubi, F. (2021). Characterization of pathways involved in colorectal cancer using real-time RT-PCR gene expression data. Gastroenterology and Hepatology from Bed to Bench, 14(2), 123-131.
    DOI Scopus7
    2021 Motalebzadeh, J., & Eskandari, E. (2021). Transcription Factors Linked to the Molecular Signatures in the Development of HCC on a Cirrhotic Background.
    DOI
    2021 Motalebzadeh, J., & Eskandari, E. (2021). Transcription factors linked to the molecular signatures in the development of hepatocellular carcinoma on a cirrhotic background. Medical Oncology, 38(10), 12 pages.
    DOI Scopus3 WoS3 Europe PMC2
    2020 Motalebzadeh, J., & Eskandari, E. (2020). Syntrophin beta 1 (SNTB1): Candidate as a new marker for colorectal cancer metastasis. Gene Reports, 20, 7 pages.
    DOI Scopus2 WoS2
    2019 Eskandari, E., & Motalebzadeh, J. (2019). Transcriptomics-based screening of molecular signatures associated with patients overall survival and their key regulators in subtypes of breast cancer. Cancer Genetics, 239, 62-74.
    DOI Scopus7 WoS6 Europe PMC8
    2018 Motalebzadeh, J., Shabani, S., Rezayati, S., Shakournia, N., Mirzaei, R., Mahjoubi, B., . . . Mahjoubi, F. (2018). Prognostic value of FBXO39 and ETS-1 but not BMI-1 in Iranian colorectal cancer patients. Asian Pacific Journal of Cancer Prevention, 19(5), 1357-1362.
    DOI Scopus6 Europe PMC2
    2018 Taheri, M., Motalebzadeh, J., & Mahjoubi, F. (2018). Expression of LRP gene in breast cancer patients correlated with MRP1 as two independent predictive biomarkers in breast cancer. Asian Pacific Journal of Cancer Prevention, 19(11), 3111-3115.
    DOI Scopus4 Europe PMC1
    2018 Eskandari, E., Mahjoubi, F., & Motalebzadeh, J. (2018). An integrated study on TFs and miRNAs in colorectal cancer metastasis and evaluation of three co-regulated candidate genes as prognostic markers. Gene, 679, 150-159.
    DOI Scopus18 WoS16 Europe PMC16
    2017 Motalebzadeh, J., Mahjoubi, F., Nafissi, N., Hashemian, M., Taheri, M., & Hosseinpour, Y. (2017). FBLN-4 and BCRP genes as two prognostic markers are downregulated in breast cancer tissue. Cancer Biomarkers, 19(1), 51-55.
    DOI Scopus7 WoS4 Europe PMC5

  • Conference Papers
    Year Citation
    2017 Motalebzadeh, J., Mahjoubi, F., Eskandari, E., Rezayati, S., Shakournia, N., & Ayoubi, H. A. (2017). FBXO39, ETS-1 and H3F3B genes as three candidates for prognosis of colorectal cancer metastasis. In EUROPEAN JOURNAL OF CANCER Vol. 72 (pp. S137). Amsterdam, NETHERLANDS: ELSEVIER SCI LTD.
    DOI

More than five years experience in bioinformatics and genetics.

Connect With Me
External Profiles